Literature DB >> 2201206

Endothelin in experimental congestive heart failure in the anesthetized dog.

P G Cavero1, W L Miller, D M Heublein, K B Margulies, J C Burnett.   

Abstract

Studies were performed in anesthetized dogs to determine plasma endothelin (ET) concentrations in the presence and absence of experimental congestive heart failure (CHF) produced by rapid ventricular pacing for 8 days. These studies were also designed to determine the effect of exogenous low-dose ET upon integrated cardiorenal and endocrine function in the presence and absence of CHF. In these studies, plasma ET was significantly elevated in CHF (3.25 +/- 0.39 pg/ml) compared with normal (1.03 +/- 0.21 pg/ml) or sham-operated (1.08 +/- 0.27 pg/ml) groups. Compared with the control group, which was characterized by a significant cardiorenal vasoconstrictor response to low-dose ET, a significant attenuation of the vasoconstrictor and antinatriuretic actions of ET was observed in the CHF group. Despite these differential responses, exogenous ET suppressed plasma renin activity (PRA) and activated aldosterone in both control and CHF groups. Thus these studies demonstrate for the first time that experimental CHF is characterized by elevated plasma ET in association with an attenuated cardiorenal response to exogenous ET. In contrast, low-dose ET inhibited PRC and activated aldosterone in the presence and absence of experimental CHF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201206     DOI: 10.1152/ajprenal.1990.259.2.F312

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 2.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Authors:  Elise Belaidi; Jessica Morand; Emmanuelle Gras; Jean-Louis Pépin; Diane Godin-Ribuot
Journal:  Pharmacol Ther       Date:  2016-08-02       Impact factor: 12.310

3.  Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin.

Authors:  W B Weglicki; T M Phillips; A M Freedman; M M Cassidy; B F Dickens
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

4.  Intragastric alcohol causes endothelin release from feline pancreas.

Authors:  M P Lewis; P U Reber; A M Kusske; M T Toyama; K E Todd; S W Ashley; H A Reber
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

5.  Arginine vasopressin stimulates human mesangial cell production of endothelin.

Authors:  G L Bakris; R Fairbanks; A M Traish
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Angiopathy affects circulating endothelin-1 levels in type 2 diabetic patients.

Authors:  F Perfetto; R Tarquini; V de Leonardis; A Piluso; V Lombardi; B Tarquini
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

7.  Left ventricular and myocyte structure and function following chronic ventricular tachycardia in rabbits.

Authors:  F G Spinale; D M Eble; R Mukherjee; W S Johnson; J D Walker
Journal:  Basic Res Cardiol       Date:  1994 Sep-Oct       Impact factor: 17.165

8.  Rapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis.

Authors:  O Kinoshita; H Yoshimi; S Nagata; F Ishikura; K Kimura; T Yamabe; K Takagaki; K Miyatake; T Omae
Journal:  Br Heart J       Date:  1993-04

9.  Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.

Authors:  K B Margulies; M A Perrella; L J McKinley; J C Burnett
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 10.  Endothelin and myocardial ischemia.

Authors:  D Hasdai; R Kornowski; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.